AMI Asset Management Corp lessened its position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 1.3% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 66,860 shares of the semiconductor company’s stock after selling 884 shares during the quarter. Synopsys comprises 2.1% of AMI Asset Management Corp’s investment portfolio, making the stock its 26th biggest holding. AMI Asset Management Corp’s holdings in Synopsys were worth $39,786,000 at the end of the most recent quarter.
A number of other hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its stake in Synopsys by 2.1% during the 1st quarter. Vanguard Group Inc. now owns 13,829,357 shares of the semiconductor company’s stock worth $7,903,478,000 after buying an additional 278,265 shares during the last quarter. Capital World Investors grew its stake in Synopsys by 12.5% during the 1st quarter. Capital World Investors now owns 7,369,890 shares of the semiconductor company’s stock worth $4,211,892,000 after buying an additional 818,485 shares during the last quarter. Price T Rowe Associates Inc. MD grew its stake in Synopsys by 39.6% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 5,337,602 shares of the semiconductor company’s stock worth $3,050,441,000 after buying an additional 1,514,449 shares during the last quarter. Massachusetts Financial Services Co. MA grew its stake in Synopsys by 6.3% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 2,565,534 shares of the semiconductor company’s stock worth $1,321,019,000 after buying an additional 153,053 shares during the last quarter. Finally, Norges Bank purchased a new position in Synopsys during the 4th quarter worth approximately $1,272,143,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Synopsys Trading Down 1.6 %
Shares of SNPS traded down $8.67 during mid-day trading on Friday, hitting $539.39. The company’s stock had a trading volume of 1,053,743 shares, compared to its average volume of 1,065,036. The firm has a 50-day simple moving average of $570.87 and a 200 day simple moving average of $566.56. The firm has a market capitalization of $82.64 billion, a P/E ratio of 58.63, a P/E/G ratio of 3.58 and a beta of 1.07. Synopsys, Inc. has a 1-year low of $434.14 and a 1-year high of $629.38.
Insider Activity
In other Synopsys news, Director Mercedes Johnson sold 5,500 shares of the company’s stock in a transaction on Tuesday, May 28th. The stock was sold at an average price of $581.38, for a total value of $3,197,590.00. Following the sale, the director now owns 1,543 shares of the company’s stock, valued at $897,069.34. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, Director Mercedes Johnson sold 5,500 shares of the business’s stock in a transaction dated Tuesday, May 28th. The shares were sold at an average price of $581.38, for a total value of $3,197,590.00. Following the sale, the director now directly owns 1,543 shares in the company, valued at approximately $897,069.34. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider John F. Runkel, Jr. sold 936 shares of the stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $566.97, for a total transaction of $530,683.92. Following the completion of the sale, the insider now directly owns 20,000 shares in the company, valued at $11,339,400. The disclosure for this sale can be found here. Insiders sold 69,830 shares of company stock valued at $42,643,721 in the last three months. 0.66% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
A number of research analysts recently issued reports on SNPS shares. JPMorgan Chase & Co. raised their price target on Synopsys from $655.00 to $685.00 and gave the stock an “overweight” rating in a research note on Thursday. Rosenblatt Securities reiterated a “buy” rating and issued a $635.00 target price on shares of Synopsys in a research note on Friday. Robert W. Baird lifted their target price on Synopsys from $661.00 to $663.00 and gave the company an “outperform” rating in a research note on Thursday. Piper Sandler reiterated an “overweight” rating and issued a $687.00 target price on shares of Synopsys in a research note on Thursday. Finally, KeyCorp lifted their target price on Synopsys from $675.00 to $690.00 and gave the company an “overweight” rating in a research note on Thursday, June 27th. Eleven investment analysts have rated the stock with a buy rating, According to MarketBeat, Synopsys presently has a consensus rating of “Buy” and an average target price of $630.09.
Read Our Latest Stock Analysis on SNPS
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also
- Five stocks we like better than Synopsys
- How to Invest in Small Cap Stocks
- CAVA Stock Rallies as Earnings Confirm It’s a Top Growth Play
- Overbought Stocks Explained: Should You Trade Them?
- 3 High Short-Interest Stocks Poised for a Rate Cut Squeeze
- 3 REITs to Buy and Hold for the Long Term
- MarketBeat Week in Review – 8/19 – 8/23
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.